Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5454)
ZEVRA THERAPEUTICS, INC. (ZVRA)
Watton Corey Michael — Director
Shares
12,300
Price
$11.25
Total Value
$138.38K
Shares Held After
1,800
% of Holdings
87.2%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
4,770
Price
$114.04
Total Value
$543.96K
Shares Held After
3,985
% of Holdings
54.5%
CORCEPT THERAPEUTICS INC (CORT)
Guyer William — Chief Development Officer
Shares
11,530
Price
$113.18
Total Value
$1.30M
Shares Held After
8,755
% of Holdings
56.8%
CORCEPT THERAPEUTICS INC (CORT)
Maduck Sean — President, Corcept Endocrinology
The power of attorney under which this form was signed is on file with the Commission.
Shares
1,031
Price
$114.52
Total Value
$118.07K
Shares Held After
9,755
% of Holdings
9.6%
REGENERON PHARMACEUTICALS, INC. (REGN)
Guarini Kathryn — Director
Shares
400
Price
$800.00
Total Value
$320.00K
Shares Held After
603
% of Holdings
39.9%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
8,370
Price
$46.75
Total Value
$391.28K
Shares Held After
515,066
% of Holdings
1.6%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
14,171
Price
$45.97
Total Value
$651.49K
Shares Held After
523,436
% of Holdings
2.6%
Twist Bioscience Corp (TWST)
Leproust Emily M. — Director
Shares
113,318
Price
$125.16
Total Value
$14.18M
Shares Held After
818,938
% of Holdings
12.2%
NextCure, Inc. (NXTC)
Simcere Zaiming, Inc. — Former 10% Owner
Shares
30,000
Price
$6.16
Total Value
$184.80K
Shares Held After
308,636
% of Holdings
8.9%
Anteris Technologies Global Corp. (AVR)
L1 Capital Pty Ltd — 10% Owner
Shares
251,844
Price
$9.10
Total Value
$2.29M
Shares Held After
5,187,156
% of Holdings
4.6%
ANI PHARMACEUTICALS INC (ANIP)
Gutwerg Ori — SVP, GENERICS
Shares
3,162
Price
$77.00
Total Value
$243.47K
Shares Held After
75,534
% of Holdings
4.0%
Guardant Health, Inc. (GH)
Freeman Chris — Chief Commercial Officer
Shares
17,413
Price
$170.24
Total Value
$2.96M
Shares Held After
65,374
% of Holdings
21.0%
Guardant Health, Inc. (GH)
Freeman Chris — Chief Commercial Officer
Shares
35,364
Price
$169.63
Total Value
$6.00M
Shares Held After
82,787
% of Holdings
29.9%
Guardant Health, Inc. (GH)
Freeman Chris — Chief Commercial Officer
Shares
7,365
Price
$168.79
Total Value
$1.24M
Shares Held After
118,151
% of Holdings
5.9%
Guardant Health, Inc. (GH)
Freeman Chris — Chief Commercial Officer
Shares
3,463
Price
$167.38
Total Value
$579.64K
Shares Held After
125,516
% of Holdings
2.7%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
2,300
Price
$100.14
Total Value
$230.32K
Shares Held After
194,309
% of Holdings
1.2%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
6,017
Price
$99.25
Total Value
$597.19K
Shares Held After
196,609
% of Holdings
3.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Peetz Christopher — Director
Shares
11,683
Price
$98.51
Total Value
$1.15M
Shares Held After
202,626
% of Holdings
5.5%
HALOZYME THERAPEUTICS, INC. (HALO)
Connaughton Bernadette — Director
Shares
1,626
Price
$102.80
Total Value
$167.15K
Shares Held After
40,418
% of Holdings
3.9%
INTUITIVE SURGICAL INC (ISRG)
Ladd Amy L — Director
Shares
400
Price
$379.00
Total Value
$151.60K
Shares Held After
251
% of Holdings
61.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
397
Price
$111.77
Total Value
$44.37K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
470
Price
$111.05
Total Value
$52.19K
Shares Held After
397
% of Holdings
54.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
272
Price
$109.96
Total Value
$29.91K
Shares Held After
867
% of Holdings
23.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
831
Price
$108.95
Total Value
$90.54K
Shares Held After
1,139
% of Holdings
42.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
737
Price
$108.17
Total Value
$79.72K
Shares Held After
1,970
% of Holdings
27.2%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
70
Price
$107.11
Total Value
$7.50K
Shares Held After
2,707
% of Holdings
2.5%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
McGeorge Anne — Director
Shares
700
Price
$111.41
Total Value
$77.99K
Shares Held After
0
% of Holdings
100.0%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
McGeorge Anne — Director
Shares
1,000
Price
$110.64
Total Value
$110.64K
Shares Held After
700
% of Holdings
58.8%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
McGeorge Anne — Director
Shares
1,800
Price
$109.30
Total Value
$196.74K
Shares Held After
1,700
% of Holdings
51.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
McGeorge Anne — Director
Shares
2,800
Price
$108.38
Total Value
$303.46K
Shares Held After
3,500
% of Holdings
44.4%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
McGeorge Anne — Director
Shares
1,450
Price
$107.58
Total Value
$155.99K
Shares Held After
6,300
% of Holdings
18.7%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Veness Adam M — SVP, General Counsel and Sec.
Shares
16,167
Price
$110.38
Total Value
$1.78M
Shares Held After
0
% of Holdings
100.0%
Lyell Immunopharma, Inc. (LYEL)
Seely Lynn — Director
Shares
390
Price
$14.34
Total Value
$5.59K
Shares Held After
73,488
% of Holdings
0.5%
ICON PLC (ICLR)
Balfe Barry Edward — Director
Shares
78
Price
$165.14
Total Value
$12.88K
Shares Held After
4,804
% of Holdings
1.6%
ICON PLC (ICLR)
Balfe Barry Edward — Director
Shares
304
Price
$163.80
Total Value
$49.80K
Shares Held After
4,882
% of Holdings
5.9%
Lyell Immunopharma, Inc. (LYEL)
Bulis Veronica Sanchez — VP, Corporate Controller
Shares
621
Price
$14.34
Total Value
$8.91K
Shares Held After
14,799
% of Holdings
4.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
214
Price
$538.86
Total Value
$115.32K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
186
Price
$537.91
Total Value
$100.05K
Shares Held After
324,657
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
514
Price
$536.23
Total Value
$275.62K
Shares Held After
324,843
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
286
Price
$535.27
Total Value
$153.09K
Shares Held After
325,357
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
391
Price
$533.21
Total Value
$208.49K
Shares Held After
325,643
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
459
Price
$532.28
Total Value
$244.32K
Shares Held After
326,034
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
640
Price
$531.15
Total Value
$339.94K
Shares Held After
326,493
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
3,027
Price
$530.26
Total Value
$1.61M
Shares Held After
327,133
% of Holdings
0.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,050
Price
$529.27
Total Value
$555.73K
Shares Held After
330,160
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
731
Price
$528.40
Total Value
$386.26K
Shares Held After
331,210
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
722
Price
$527.38
Total Value
$380.77K
Shares Held After
331,941
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
120
Price
$525.73
Total Value
$63.09K
Shares Held After
332,663
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
582
Price
$524.86
Total Value
$305.47K
Shares Held After
332,783
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
578
Price
$523.95
Total Value
$302.84K
Shares Held After
333,365
% of Holdings
0.2%
Showing 151–200 of 5454 transactions (page 4 of 110)